Abstract

BackgroundDiabetic mellitus and periodontal disease have bilateral associations. However, there is a dilemma on the effect of periodontal therapy on glycemic control and/or fasting plasma glucose level in type 2 diabetic patients with periodontitis. Therefore, this review aimed to assess the effectiveness of periodontal therapy versus no periodontal therapy on glycated hemoglobin (HbA1c) and fasting plasma glucose level in type 2 diabetic patients.MethodsArticle searching was done using four databases (MEDLINE, Cochrane library (CENTRAL), EMBASE and CINAHL) and a manual search (until December 2015). We included randomized controlled trials testing the effectiveness of periodontal therapy on glycated hemoglobin and fasting plasma glucose level in patients with type 2 Diabetes mellitus with periodontal disease. Studies published in English between 2005 and 2015 were included. Risk of bias was assessed regarding randomization, allocation sequence concealment, blinding, incomplete outcome data, selective outcome reporting, and other biases.ResultsAfter the article selection process, seven Randomized controlled trials involving 940 participants with a primary outcome of change in glycated hemoglobin and/or fasting plasma glucose and having a minimum of 3 months follow-up were included.There was a reduction of glycated hemoglobin 0.48(95 % CI: 0.18–0.78) after 3 months follow-up and 0.53 (95 % CI: 0.24–0.81) at the end of the intervention period.There was also a significant reduction of fasting plasma glucose level, 8.95 mg/dl (95 % CI: 4.30–13.61) in the intervention group after the end of the intervention. The pooled analysis showed that patients with adjunctive antibiotic therapy and mouth wash had effect size of 0.51(0.03, 1.00, p = 0.04) and it was 0.53 (95 % CI: 0.19, 0.87; p = 0.002) in patients without adjunctive therapy. The publication bias of the studies was 0.066 according to Egger’s test.ConclusionIn this systematic review and meta-analysis, there is a significant reduction of Glycated hemoglobin and Fasting plasma glucose level on type 2 diabetic and periodontal patients with non-surgical periodontal therapy.

Highlights

  • Diabetic mellitus and periodontal disease have bilateral associations

  • Eligibility criteria The types of included studies were Randomized controlled trials (RCTs) which studied the effectiveness of periodontal therapy on glycemic control and/or fasting plasma glucose level in type 2 diabetes mellitus (DM) with periodontitis

  • Results of individual studies The effect of periodontal therapy on glycemic control of type 2 diabetic patients was analyzed from the available randomized clinical trial studies

Read more

Summary

Introduction

Diabetic mellitus and periodontal disease have bilateral associations. There is a dilemma on the effect of periodontal therapy on glycemic control and/or fasting plasma glucose level in type 2 diabetic patients with periodontitis. This review aimed to assess the effectiveness of periodontal therapy versus no periodontal therapy on glycated hemoglobin (HbA1c) and fasting plasma glucose level in type 2 diabetic patients. The frequency and severity of periodontitis are more in patients with systemic diseases (HIV/AIDS, diabetes mellitus (DM), and cardiovascular disease) and on pregnancy than healthy individuals [2]. Periodontal disease and DM are the two major chronic diseases which have a devastating effect on the health and wellbeing of millions of individuals globally. An emerging body of evidence has been reported that periodontal disease causes poor glycemic control and induced diabetes-related complications [5, 6]

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call